nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CYP3A4—Pilocarpine—glaucoma	0.0495	0.166	CbGbCtD
Naloxone—ABCB1—Timolol—glaucoma	0.0475	0.159	CbGbCtD
Naloxone—ABCB1—Clonidine—glaucoma	0.0404	0.135	CbGbCtD
Naloxone—CYP3A4—Brinzolamide—glaucoma	0.0389	0.13	CbGbCtD
Naloxone—CYP3A4—Dorzolamide—glaucoma	0.0375	0.126	CbGbCtD
Naloxone—CYP3A4—Methazolamide—glaucoma	0.0335	0.112	CbGbCtD
Naloxone—CYP3A4—Acetazolamide—glaucoma	0.0267	0.0897	CbGbCtD
Naloxone—CYP3A4—Clonidine—glaucoma	0.0242	0.0811	CbGbCtD
Naloxone—Depression—Brimonidine—glaucoma	0.00177	0.00428	CcSEcCtD
Naloxone—Hyperhidrosis—Carbachol—glaucoma	0.00175	0.00422	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00171	0.00413	CcSEcCtD
Naloxone—Depression—Dorzolamide—glaucoma	0.00169	0.00409	CcSEcCtD
Naloxone—Angiopathy—Apraclonidine—glaucoma	0.00169	0.00407	CcSEcCtD
Naloxone—Depression—Travoprost—glaucoma	0.00168	0.00407	CcSEcCtD
Naloxone—Dyspnoea—Carteolol—glaucoma	0.00168	0.00406	CcSEcCtD
Naloxone—Mediastinal disorder—Apraclonidine—glaucoma	0.00167	0.00404	CcSEcCtD
Naloxone—Paraesthesia—Diclofenamide—glaucoma	0.00166	0.00402	CcSEcCtD
Naloxone—Depression—Brinzolamide—glaucoma	0.00166	0.00402	CcSEcCtD
Naloxone—Angiopathy—Bimatoprost—glaucoma	0.00163	0.00395	CcSEcCtD
Naloxone—Mental disorder—Apraclonidine—glaucoma	0.00163	0.00393	CcSEcCtD
Naloxone—Sweating—Dorzolamide—glaucoma	0.00163	0.00393	CcSEcCtD
Naloxone—Mediastinal disorder—Bimatoprost—glaucoma	0.00162	0.00392	CcSEcCtD
Naloxone—Nervous system disorder—Latanoprost—glaucoma	0.00162	0.00391	CcSEcCtD
Naloxone—Skin disorder—Latanoprost—glaucoma	0.0016	0.00387	CcSEcCtD
Naloxone—Gastrointestinal disorder—Diclofenamide—glaucoma	0.0016	0.00386	CcSEcCtD
Naloxone—Paraesthesia—Levobunolol—glaucoma	0.0016	0.00386	CcSEcCtD
Naloxone—Dyspnoea—Levobunolol—glaucoma	0.00159	0.00383	CcSEcCtD
Naloxone—Tension—Apraclonidine—glaucoma	0.00159	0.00383	CcSEcCtD
Naloxone—Irritability—Clonidine—glaucoma	0.00159	0.00383	CcSEcCtD
Naloxone—Nervousness—Apraclonidine—glaucoma	0.00157	0.00379	CcSEcCtD
Naloxone—Pain—Carbachol—glaucoma	0.00155	0.00373	CcSEcCtD
Naloxone—Flushing—Acetazolamide—glaucoma	0.00154	0.00373	CcSEcCtD
Naloxone—Tension—Bimatoprost—glaucoma	0.00154	0.00372	CcSEcCtD
Naloxone—Sweating—Pilocarpine—glaucoma	0.00154	0.00371	CcSEcCtD
Naloxone—Paraesthesia—Methazolamide—glaucoma	0.00153	0.0037	CcSEcCtD
Naloxone—Nervousness—Bimatoprost—glaucoma	0.00152	0.00368	CcSEcCtD
Naloxone—Pain—Levobunolol—glaucoma	0.00152	0.00368	CcSEcCtD
Naloxone—Hallucination—Dorzolamide—glaucoma	0.00152	0.00366	CcSEcCtD
Naloxone—Nasopharyngitis—Clonidine—glaucoma	0.00149	0.00359	CcSEcCtD
Naloxone—Flushing—Brimonidine—glaucoma	0.00148	0.00358	CcSEcCtD
Naloxone—Cardiac disorder—Brimonidine—glaucoma	0.00148	0.00358	CcSEcCtD
Naloxone—Gastrointestinal disorder—Methazolamide—glaucoma	0.00147	0.00356	CcSEcCtD
Naloxone—Dyspnoea—Latanoprost—glaucoma	0.00147	0.00356	CcSEcCtD
Naloxone—Body temperature increased—Diclofenamide—glaucoma	0.00146	0.00354	CcSEcCtD
Naloxone—Asthenia—Metipranolol—glaucoma	0.00146	0.00352	CcSEcCtD
Naloxone—Pulmonary oedema—Timolol—glaucoma	0.00145	0.0035	CcSEcCtD
Naloxone—Angiopathy—Brimonidine—glaucoma	0.00145	0.0035	CcSEcCtD
Naloxone—Mediastinal disorder—Brimonidine—glaucoma	0.00144	0.00347	CcSEcCtD
Naloxone—Body temperature increased—Carbachol—glaucoma	0.00143	0.00345	CcSEcCtD
Naloxone—Abdominal pain—Carbachol—glaucoma	0.00143	0.00345	CcSEcCtD
Naloxone—Pain—Latanoprost—glaucoma	0.00141	0.00341	CcSEcCtD
Naloxone—Cardiac disorder—Travoprost—glaucoma	0.00141	0.0034	CcSEcCtD
Naloxone—Mental disorder—Brimonidine—glaucoma	0.0014	0.00338	CcSEcCtD
Naloxone—Cardiac disorder—Brinzolamide—glaucoma	0.00139	0.00336	CcSEcCtD
Naloxone—Angiopathy—Travoprost—glaucoma	0.00138	0.00332	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00137	0.0033	CcSEcCtD
Naloxone—Mediastinal disorder—Travoprost—glaucoma	0.00137	0.0033	CcSEcCtD
Naloxone—Angiopathy—Brinzolamide—glaucoma	0.00136	0.00328	CcSEcCtD
Naloxone—Hypertension—Bimatoprost—glaucoma	0.00135	0.00327	CcSEcCtD
Naloxone—Asthenia—Carteolol—glaucoma	0.00135	0.00327	CcSEcCtD
Naloxone—Mediastinal disorder—Brinzolamide—glaucoma	0.00135	0.00326	CcSEcCtD
Naloxone—Body temperature increased—Methazolamide—glaucoma	0.00135	0.00326	CcSEcCtD
Naloxone—Flushing—Pilocarpine—glaucoma	0.00134	0.00323	CcSEcCtD
Naloxone—Agitation—Acetazolamide—glaucoma	0.00133	0.00321	CcSEcCtD
Naloxone—Asthenia—Diclofenamide—glaucoma	0.00133	0.00321	CcSEcCtD
Naloxone—Mental disorder—Travoprost—glaucoma	0.00133	0.00321	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00133	0.0032	CcSEcCtD
Naloxone—Mental disorder—Brinzolamide—glaucoma	0.00131	0.00317	CcSEcCtD
Naloxone—Tension—Dorzolamide—glaucoma	0.0013	0.00314	CcSEcCtD
Naloxone—Nervous system disorder—Apraclonidine—glaucoma	0.00129	0.00313	CcSEcCtD
Naloxone—Nasopharyngitis—Betaxolol—glaucoma	0.00129	0.00312	CcSEcCtD
Naloxone—Chills—Pilocarpine—glaucoma	0.00129	0.00312	CcSEcCtD
Naloxone—Nervousness—Dorzolamide—glaucoma	0.00129	0.00311	CcSEcCtD
Naloxone—Skin disorder—Apraclonidine—glaucoma	0.00128	0.0031	CcSEcCtD
Naloxone—Tension—Brinzolamide—glaucoma	0.00128	0.00309	CcSEcCtD
Naloxone—Asthenia—Levobunolol—glaucoma	0.00128	0.00309	CcSEcCtD
Naloxone—Depression—Clonidine—glaucoma	0.00128	0.00308	CcSEcCtD
Naloxone—Nervousness—Brinzolamide—glaucoma	0.00127	0.00306	CcSEcCtD
Naloxone—Nervous system disorder—Bimatoprost—glaucoma	0.00126	0.00303	CcSEcCtD
Naloxone—Convulsion—Acetazolamide—glaucoma	0.00125	0.00303	CcSEcCtD
Naloxone—Skin disorder—Bimatoprost—glaucoma	0.00124	0.003	CcSEcCtD
Naloxone—Diarrhoea—Carbachol—glaucoma	0.00124	0.00299	CcSEcCtD
Naloxone—Tension—Pilocarpine—glaucoma	0.00123	0.00297	CcSEcCtD
Naloxone—Sweating—Clonidine—glaucoma	0.00123	0.00296	CcSEcCtD
Naloxone—Asthenia—Methazolamide—glaucoma	0.00122	0.00296	CcSEcCtD
Naloxone—Tremor—Brinzolamide—glaucoma	0.00122	0.00295	CcSEcCtD
Naloxone—Diarrhoea—Levobunolol—glaucoma	0.00122	0.00294	CcSEcCtD
Naloxone—Nervousness—Pilocarpine—glaucoma	0.00122	0.00294	CcSEcCtD
Naloxone—Nausea—Metipranolol—glaucoma	0.00121	0.00292	CcSEcCtD
Naloxone—Hypertension—Brimonidine—glaucoma	0.0012	0.0029	CcSEcCtD
Naloxone—Agitation—Brinzolamide—glaucoma	0.0012	0.00289	CcSEcCtD
Naloxone—Paraesthesia—Apraclonidine—glaucoma	0.00119	0.00286	CcSEcCtD
Naloxone—Vomiting—Diclofenamide—glaucoma	0.00118	0.00284	CcSEcCtD
Naloxone—Dyspnoea—Apraclonidine—glaucoma	0.00118	0.00284	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00117	0.00284	CcSEcCtD
Naloxone—Tremor—Pilocarpine—glaucoma	0.00117	0.00284	CcSEcCtD
Naloxone—Diarrhoea—Methazolamide—glaucoma	0.00117	0.00282	CcSEcCtD
Naloxone—Agitation—Pilocarpine—glaucoma	0.00115	0.00278	CcSEcCtD
Naloxone—Vomiting—Carbachol—glaucoma	0.00115	0.00278	CcSEcCtD
Naloxone—Hypertension—Dorzolamide—glaucoma	0.00115	0.00277	CcSEcCtD
Naloxone—Hallucination—Clonidine—glaucoma	0.00114	0.00276	CcSEcCtD
Naloxone—Dyspnoea—Bimatoprost—glaucoma	0.00114	0.00276	CcSEcCtD
Naloxone—Hypertension—Travoprost—glaucoma	0.00114	0.00275	CcSEcCtD
Naloxone—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00114	0.00275	CcSEcCtD
Naloxone—Pain—Apraclonidine—glaucoma	0.00113	0.00273	CcSEcCtD
Naloxone—Hypertension—Brinzolamide—glaucoma	0.00113	0.00272	CcSEcCtD
Naloxone—Cardiac arrest—Timolol—glaucoma	0.00112	0.00271	CcSEcCtD
Naloxone—Nausea—Carteolol—glaucoma	0.00112	0.0027	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00112	0.0027	CcSEcCtD
Naloxone—Depression—Betaxolol—glaucoma	0.00111	0.00268	CcSEcCtD
Naloxone—Nervous system disorder—Brimonidine—glaucoma	0.00111	0.00268	CcSEcCtD
Naloxone—Tachycardia—Brimonidine—glaucoma	0.00111	0.00267	CcSEcCtD
Naloxone—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00111	0.00267	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.0011	0.00266	CcSEcCtD
Naloxone—Skin disorder—Brimonidine—glaucoma	0.0011	0.00266	CcSEcCtD
Naloxone—Nausea—Diclofenamide—glaucoma	0.0011	0.00266	CcSEcCtD
Naloxone—Pain—Bimatoprost—glaucoma	0.00109	0.00264	CcSEcCtD
Naloxone—Vomiting—Methazolamide—glaucoma	0.00108	0.00262	CcSEcCtD
Naloxone—Hypertension—Pilocarpine—glaucoma	0.00108	0.00261	CcSEcCtD
Naloxone—Nausea—Carbachol—glaucoma	0.00107	0.00259	CcSEcCtD
Naloxone—Sweating—Betaxolol—glaucoma	0.00107	0.00258	CcSEcCtD
Naloxone—Cardiac disorder—Clonidine—glaucoma	0.00107	0.00258	CcSEcCtD
Naloxone—Paraesthesia—Acetazolamide—glaucoma	0.00106	0.00256	CcSEcCtD
Naloxone—Nausea—Levobunolol—glaucoma	0.00106	0.00255	CcSEcCtD
Naloxone—Nervous system disorder—Travoprost—glaucoma	0.00106	0.00255	CcSEcCtD
Naloxone—Nasopharyngitis—Timolol—glaucoma	0.00106	0.00255	CcSEcCtD
Naloxone—Tachycardia—Travoprost—glaucoma	0.00105	0.00254	CcSEcCtD
Naloxone—Skin disorder—Travoprost—glaucoma	0.00105	0.00253	CcSEcCtD
Naloxone—Hyperhidrosis—Dorzolamide—glaucoma	0.00105	0.00253	CcSEcCtD
Naloxone—Abdominal pain—Apraclonidine—glaucoma	0.00104	0.00252	CcSEcCtD
Naloxone—Nervous system disorder—Brinzolamide—glaucoma	0.00104	0.00252	CcSEcCtD
Naloxone—Angiopathy—Clonidine—glaucoma	0.00104	0.00252	CcSEcCtD
Naloxone—Tachycardia—Brinzolamide—glaucoma	0.00104	0.00251	CcSEcCtD
Naloxone—Mediastinal disorder—Clonidine—glaucoma	0.00104	0.0025	CcSEcCtD
Naloxone—Skin disorder—Brinzolamide—glaucoma	0.00103	0.0025	CcSEcCtD
Naloxone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00102	0.00246	CcSEcCtD
Naloxone—Paraesthesia—Brimonidine—glaucoma	0.00102	0.00246	CcSEcCtD
Naloxone—Nausea—Methazolamide—glaucoma	0.00101	0.00245	CcSEcCtD
Naloxone—Dyspnoea—Brimonidine—glaucoma	0.00101	0.00244	CcSEcCtD
Naloxone—Mental disorder—Clonidine—glaucoma	0.00101	0.00243	CcSEcCtD
Naloxone—Tachycardia—Pilocarpine—glaucoma	0.000998	0.00241	CcSEcCtD
Naloxone—Hallucination—Betaxolol—glaucoma	0.000996	0.0024	CcSEcCtD
Naloxone—Hyperhidrosis—Pilocarpine—glaucoma	0.000989	0.00239	CcSEcCtD
Naloxone—Tension—Clonidine—glaucoma	0.000982	0.00237	CcSEcCtD
Naloxone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000979	0.00236	CcSEcCtD
Naloxone—Nervousness—Clonidine—glaucoma	0.000972	0.00235	CcSEcCtD
Naloxone—Paraesthesia—Dorzolamide—glaucoma	0.000972	0.00235	CcSEcCtD
Naloxone—Pain—Brimonidine—glaucoma	0.000969	0.00234	CcSEcCtD
Naloxone—Dyspnoea—Dorzolamide—glaucoma	0.000965	0.00233	CcSEcCtD
Naloxone—Dyspnoea—Travoprost—glaucoma	0.000961	0.00232	CcSEcCtD
Naloxone—Paraesthesia—Brinzolamide—glaucoma	0.000956	0.00231	CcSEcCtD
Naloxone—Dyspnoea—Brinzolamide—glaucoma	0.000949	0.00229	CcSEcCtD
Naloxone—Asthenia—Apraclonidine—glaucoma	0.000947	0.00229	CcSEcCtD
Naloxone—Tremor—Clonidine—glaucoma	0.000938	0.00226	CcSEcCtD
Naloxone—Body temperature increased—Acetazolamide—glaucoma	0.000934	0.00225	CcSEcCtD
Naloxone—Gastrointestinal disorder—Travoprost—glaucoma	0.00093	0.00225	CcSEcCtD
Naloxone—Flushing—Betaxolol—glaucoma	0.000929	0.00224	CcSEcCtD
Naloxone—Cardiac disorder—Betaxolol—glaucoma	0.000929	0.00224	CcSEcCtD
Naloxone—Pain—Dorzolamide—glaucoma	0.000926	0.00224	CcSEcCtD
Naloxone—Pain—Travoprost—glaucoma	0.000922	0.00223	CcSEcCtD
Naloxone—Agitation—Clonidine—glaucoma	0.00092	0.00222	CcSEcCtD
Naloxone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000919	0.00222	CcSEcCtD
Naloxone—Paraesthesia—Pilocarpine—glaucoma	0.000918	0.00222	CcSEcCtD
Naloxone—Asthenia—Bimatoprost—glaucoma	0.000918	0.00222	CcSEcCtD
Naloxone—Dyspnoea—Pilocarpine—glaucoma	0.000912	0.0022	CcSEcCtD
Naloxone—Pain—Brinzolamide—glaucoma	0.00091	0.0022	CcSEcCtD
Naloxone—Depression—Timolol—glaucoma	0.000908	0.00219	CcSEcCtD
Naloxone—Angiopathy—Betaxolol—glaucoma	0.000908	0.00219	CcSEcCtD
Naloxone—Diarrhoea—Apraclonidine—glaucoma	0.000903	0.00218	CcSEcCtD
Naloxone—Mediastinal disorder—Betaxolol—glaucoma	0.000902	0.00218	CcSEcCtD
Naloxone—Chills—Betaxolol—glaucoma	0.000898	0.00217	CcSEcCtD
Naloxone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000883	0.00213	CcSEcCtD
Naloxone—Mental disorder—Betaxolol—glaucoma	0.000877	0.00212	CcSEcCtD
Naloxone—Pain—Pilocarpine—glaucoma	0.000875	0.00211	CcSEcCtD
Naloxone—Sweating—Timolol—glaucoma	0.000873	0.00211	CcSEcCtD
Naloxone—Abdominal pain—Dorzolamide—glaucoma	0.000856	0.00207	CcSEcCtD
Naloxone—Body temperature increased—Dorzolamide—glaucoma	0.000856	0.00207	CcSEcCtD
Naloxone—Tension—Betaxolol—glaucoma	0.000855	0.00206	CcSEcCtD
Naloxone—Abdominal pain—Travoprost—glaucoma	0.000852	0.00206	CcSEcCtD
Naloxone—Asthenia—Acetazolamide—glaucoma	0.000847	0.00205	CcSEcCtD
Naloxone—Nervousness—Betaxolol—glaucoma	0.000846	0.00204	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000846	0.00204	CcSEcCtD
Naloxone—Vomiting—Apraclonidine—glaucoma	0.000839	0.00203	CcSEcCtD
Naloxone—Tremor—Betaxolol—glaucoma	0.000816	0.00197	CcSEcCtD
Naloxone—Hallucination—Timolol—glaucoma	0.000814	0.00196	CcSEcCtD
Naloxone—Asthenia—Brimonidine—glaucoma	0.000813	0.00196	CcSEcCtD
Naloxone—Abdominal pain—Pilocarpine—glaucoma	0.000809	0.00195	CcSEcCtD
Naloxone—Body temperature increased—Pilocarpine—glaucoma	0.000809	0.00195	CcSEcCtD
Naloxone—Diarrhoea—Acetazolamide—glaucoma	0.000808	0.00195	CcSEcCtD
Naloxone—Nervous system disorder—Clonidine—glaucoma	0.000801	0.00193	CcSEcCtD
Naloxone—Tachycardia—Clonidine—glaucoma	0.000797	0.00193	CcSEcCtD
Naloxone—Skin disorder—Clonidine—glaucoma	0.000793	0.00192	CcSEcCtD
Naloxone—Hyperhidrosis—Clonidine—glaucoma	0.00079	0.00191	CcSEcCtD
Naloxone—Nausea—Apraclonidine—glaucoma	0.000784	0.00189	CcSEcCtD
Naloxone—Asthenia—Dorzolamide—glaucoma	0.000777	0.00188	CcSEcCtD
Naloxone—Asthenia—Travoprost—glaucoma	0.000773	0.00187	CcSEcCtD
Naloxone—Asthenia—Brinzolamide—glaucoma	0.000764	0.00184	CcSEcCtD
Naloxone—Nausea—Bimatoprost—glaucoma	0.00076	0.00184	CcSEcCtD
Naloxone—Cardiac disorder—Timolol—glaucoma	0.000759	0.00183	CcSEcCtD
Naloxone—Vomiting—Acetazolamide—glaucoma	0.000751	0.00181	CcSEcCtD
Naloxone—Angiopathy—Timolol—glaucoma	0.000742	0.00179	CcSEcCtD
Naloxone—Diarrhoea—Dorzolamide—glaucoma	0.000741	0.00179	CcSEcCtD
Naloxone—Diarrhoea—Travoprost—glaucoma	0.000737	0.00178	CcSEcCtD
Naloxone—Mediastinal disorder—Timolol—glaucoma	0.000737	0.00178	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000737	0.00178	CcSEcCtD
Naloxone—Asthenia—Pilocarpine—glaucoma	0.000734	0.00177	CcSEcCtD
Naloxone—Paraesthesia—Clonidine—glaucoma	0.000733	0.00177	CcSEcCtD
Naloxone—Dyspnoea—Clonidine—glaucoma	0.000728	0.00176	CcSEcCtD
Naloxone—Diarrhoea—Brinzolamide—glaucoma	0.000728	0.00176	CcSEcCtD
Naloxone—Mental disorder—Timolol—glaucoma	0.000716	0.00173	CcSEcCtD
Naloxone—Gastrointestinal disorder—Clonidine—glaucoma	0.000705	0.0017	CcSEcCtD
Naloxone—Nausea—Acetazolamide—glaucoma	0.000701	0.00169	CcSEcCtD
Naloxone—Diarrhoea—Pilocarpine—glaucoma	0.0007	0.00169	CcSEcCtD
Naloxone—Tension—Timolol—glaucoma	0.000698	0.00169	CcSEcCtD
Naloxone—Pain—Clonidine—glaucoma	0.000698	0.00169	CcSEcCtD
Naloxone—Nervous system disorder—Betaxolol—glaucoma	0.000697	0.00168	CcSEcCtD
Naloxone—Tachycardia—Betaxolol—glaucoma	0.000694	0.00168	CcSEcCtD
Naloxone—Nervousness—Timolol—glaucoma	0.000691	0.00167	CcSEcCtD
Naloxone—Skin disorder—Betaxolol—glaucoma	0.000691	0.00167	CcSEcCtD
Naloxone—Vomiting—Dorzolamide—glaucoma	0.000688	0.00166	CcSEcCtD
Naloxone—Hyperhidrosis—Betaxolol—glaucoma	0.000687	0.00166	CcSEcCtD
Naloxone—Vomiting—Brinzolamide—glaucoma	0.000677	0.00163	CcSEcCtD
Naloxone—Nausea—Brimonidine—glaucoma	0.000673	0.00163	CcSEcCtD
Naloxone—Vomiting—Pilocarpine—glaucoma	0.00065	0.00157	CcSEcCtD
Naloxone—Abdominal pain—Clonidine—glaucoma	0.000646	0.00156	CcSEcCtD
Naloxone—Body temperature increased—Clonidine—glaucoma	0.000646	0.00156	CcSEcCtD
Naloxone—Nausea—Dorzolamide—glaucoma	0.000643	0.00155	CcSEcCtD
Naloxone—Nausea—Travoprost—glaucoma	0.00064	0.00155	CcSEcCtD
Naloxone—Paraesthesia—Betaxolol—glaucoma	0.000639	0.00154	CcSEcCtD
Naloxone—Dyspnoea—Betaxolol—glaucoma	0.000634	0.00153	CcSEcCtD
Naloxone—Nausea—Brinzolamide—glaucoma	0.000632	0.00153	CcSEcCtD
Naloxone—Hypertension—Timolol—glaucoma	0.000615	0.00148	CcSEcCtD
Naloxone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000614	0.00148	CcSEcCtD
Naloxone—Pain—Betaxolol—glaucoma	0.000608	0.00147	CcSEcCtD
Naloxone—Nausea—Pilocarpine—glaucoma	0.000608	0.00147	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000602	0.00145	CcSEcCtD
Naloxone—Asthenia—Clonidine—glaucoma	0.000586	0.00142	CcSEcCtD
Naloxone—Nervous system disorder—Timolol—glaucoma	0.00057	0.00138	CcSEcCtD
Naloxone—Skin disorder—Timolol—glaucoma	0.000564	0.00136	CcSEcCtD
Naloxone—Body temperature increased—Betaxolol—glaucoma	0.000562	0.00136	CcSEcCtD
Naloxone—Hyperhidrosis—Timolol—glaucoma	0.000562	0.00136	CcSEcCtD
Naloxone—Diarrhoea—Clonidine—glaucoma	0.000559	0.00135	CcSEcCtD
Naloxone—Paraesthesia—Timolol—glaucoma	0.000522	0.00126	CcSEcCtD
Naloxone—Vomiting—Clonidine—glaucoma	0.000519	0.00125	CcSEcCtD
Naloxone—Dyspnoea—Timolol—glaucoma	0.000518	0.00125	CcSEcCtD
Naloxone—Asthenia—Betaxolol—glaucoma	0.00051	0.00123	CcSEcCtD
Naloxone—Gastrointestinal disorder—Timolol—glaucoma	0.000502	0.00121	CcSEcCtD
Naloxone—Pain—Timolol—glaucoma	0.000497	0.0012	CcSEcCtD
Naloxone—Diarrhoea—Betaxolol—glaucoma	0.000487	0.00117	CcSEcCtD
Naloxone—Nausea—Clonidine—glaucoma	0.000485	0.00117	CcSEcCtD
Naloxone—Abdominal pain—Timolol—glaucoma	0.000459	0.00111	CcSEcCtD
Naloxone—Body temperature increased—Timolol—glaucoma	0.000459	0.00111	CcSEcCtD
Naloxone—Vomiting—Betaxolol—glaucoma	0.000452	0.00109	CcSEcCtD
Naloxone—Nausea—Betaxolol—glaucoma	0.000422	0.00102	CcSEcCtD
Naloxone—Asthenia—Timolol—glaucoma	0.000417	0.00101	CcSEcCtD
Naloxone—Diarrhoea—Timolol—glaucoma	0.000397	0.00096	CcSEcCtD
Naloxone—Vomiting—Timolol—glaucoma	0.000369	0.000892	CcSEcCtD
Naloxone—Nausea—Timolol—glaucoma	0.000345	0.000833	CcSEcCtD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000104	0.00036	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—C3—glaucoma	0.000103	0.000359	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—MMP9—glaucoma	0.0001	0.000347	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RPTOR—glaucoma	9.99e-05	0.000347	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—glaucoma	9.94e-05	0.000345	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HEYL—glaucoma	9.87e-05	0.000343	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—BAD—glaucoma	9.77e-05	0.000339	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NCK2—glaucoma	9.67e-05	0.000336	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—VEGFA—glaucoma	9.62e-05	0.000334	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.59e-05	0.000333	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—glaucoma	9.58e-05	0.000333	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTGFR—glaucoma	9.56e-05	0.000332	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP2—glaucoma	9.49e-05	0.00033	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HDAC9—glaucoma	9.41e-05	0.000327	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—TXN—glaucoma	9.41e-05	0.000327	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—BAD—glaucoma	9.38e-05	0.000326	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HDAC9—glaucoma	9.38e-05	0.000326	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	9.29e-05	0.000323	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—SMO—glaucoma	9.21e-05	0.00032	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—EDN1—glaucoma	9.02e-05	0.000313	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—VEGFA—glaucoma	8.98e-05	0.000312	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	8.97e-05	0.000312	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	8.96e-05	0.000311	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	8.84e-05	0.000307	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.74e-05	0.000304	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—TNF—glaucoma	8.63e-05	0.0003	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.58e-05	0.000298	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.5e-05	0.000295	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RPTOR—glaucoma	8.44e-05	0.000293	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	8.43e-05	0.000293	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TNF—glaucoma	8.25e-05	0.000287	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB2—glaucoma	8.23e-05	0.000286	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HDAC9—glaucoma	8.22e-05	0.000286	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EDN1—glaucoma	8.22e-05	0.000286	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.2e-05	0.000285	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EDN1—glaucoma	8.19e-05	0.000285	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	8.18e-05	0.000284	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NCK2—glaucoma	8.17e-05	0.000284	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—EDN1—glaucoma	7.91e-05	0.000275	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NARFL—glaucoma	7.88e-05	0.000274	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CA5A—glaucoma	7.88e-05	0.000274	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—C3—glaucoma	7.88e-05	0.000274	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7.69e-05	0.000267	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.66e-05	0.000266	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RPTOR—glaucoma	7.48e-05	0.00026	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1A—glaucoma	7.46e-05	0.000259	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SMO—glaucoma	7.36e-05	0.000256	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SMO—glaucoma	7.34e-05	0.000255	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GSTT1—glaucoma	7.29e-05	0.000253	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NCK2—glaucoma	7.25e-05	0.000252	CbGpPWpGaD
Naloxone—CREB1—Disease—CDKN2B—glaucoma	7.22e-05	0.000251	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EDN1—glaucoma	7.18e-05	0.00025	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—C3—glaucoma	7.18e-05	0.000249	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CA1—glaucoma	7.17e-05	0.000249	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.16e-05	0.000249	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—C3—glaucoma	7.16e-05	0.000249	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP9—glaucoma	7.13e-05	0.000248	CbGpPWpGaD
Naloxone—ALB—Metabolism—CA1—glaucoma	7.13e-05	0.000248	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.07e-05	0.000246	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HDAC9—glaucoma	6.95e-05	0.000242	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CTSA—glaucoma	6.95e-05	0.000241	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—C3—glaucoma	6.91e-05	0.00024	CbGpPWpGaD
Naloxone—ALB—Metabolism—CTSA—glaucoma	6.91e-05	0.00024	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CDKN1B—glaucoma	6.8e-05	0.000236	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.78e-05	0.000236	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NTRK2—glaucoma	6.73e-05	0.000234	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NTRK2—glaucoma	6.71e-05	0.000233	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—EDN1—glaucoma	6.68e-05	0.000232	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CA2—glaucoma	6.56e-05	0.000228	CbGpPWpGaD
Naloxone—CREB1—Immune System—C3—glaucoma	6.56e-05	0.000228	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CDKN1B—glaucoma	6.53e-05	0.000227	CbGpPWpGaD
Naloxone—ALB—Metabolism—CA2—glaucoma	6.52e-05	0.000227	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SMO—glaucoma	6.44e-05	0.000224	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.41e-05	0.000223	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.41e-05	0.000223	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—VEGFA—glaucoma	6.41e-05	0.000223	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.37e-05	0.000222	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.37e-05	0.000222	CbGpPWpGaD
Naloxone—CREB1—Immune System—BCL2L1—glaucoma	6.28e-05	0.000218	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—C3—glaucoma	6.27e-05	0.000218	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CA1—glaucoma	6.25e-05	0.000217	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SOD1—glaucoma	6.24e-05	0.000217	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HDAC9—glaucoma	6.16e-05	0.000214	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—EDN1—glaucoma	6.07e-05	0.000211	CbGpPWpGaD
Naloxone—CREB1—Disease—MTHFR—glaucoma	6.06e-05	0.00021	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CTSA—glaucoma	6.05e-05	0.00021	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.03e-05	0.000209	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NTRK2—glaucoma	5.89e-05	0.000205	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.88e-05	0.000204	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—C3—glaucoma	5.84e-05	0.000203	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ABCA1—glaucoma	5.81e-05	0.000202	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CYP1B1—glaucoma	5.81e-05	0.000202	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NGFR—glaucoma	5.78e-05	0.000201	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NGFR—glaucoma	5.76e-05	0.0002	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CA2—glaucoma	5.71e-05	0.000199	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.71e-05	0.000198	CbGpPWpGaD
Naloxone—CREB1—Immune System—BAD—glaucoma	5.69e-05	0.000198	CbGpPWpGaD
Naloxone—CREB1—Disease—APOE—glaucoma	5.64e-05	0.000196	CbGpPWpGaD
Naloxone—CREB1—Disease—CAV1—glaucoma	5.59e-05	0.000194	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—glaucoma	5.49e-05	0.000191	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NTRK1—glaucoma	5.49e-05	0.000191	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NTRK1—glaucoma	5.47e-05	0.00019	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SMO—glaucoma	5.44e-05	0.000189	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—C3—glaucoma	5.3e-05	0.000184	CbGpPWpGaD
Naloxone—CREB1—Disease—BAD—glaucoma	5.25e-05	0.000183	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—CDKN2B—glaucoma	5.1e-05	0.000177	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CDKN2B—glaucoma	5.06e-05	0.000176	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NGFR—glaucoma	5.05e-05	0.000175	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CDKN2B—glaucoma	5.04e-05	0.000175	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NTRK2—glaucoma	4.97e-05	0.000173	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EDN1—glaucoma	4.85e-05	0.000169	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EDN1—glaucoma	4.84e-05	0.000168	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	4.82e-05	0.000168	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SMO—glaucoma	4.82e-05	0.000168	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NTRK1—glaucoma	4.8e-05	0.000167	CbGpPWpGaD
Naloxone—ALB—Hemostasis—MMP1—glaucoma	4.76e-05	0.000165	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.75e-05	0.000165	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GSTM1—glaucoma	4.65e-05	0.000161	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TXN—glaucoma	4.62e-05	0.000161	CbGpPWpGaD
Naloxone—ALB—Metabolism—TXN—glaucoma	4.6e-05	0.00016	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CAV1—glaucoma	4.56e-05	0.000159	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NR3C1—glaucoma	4.47e-05	0.000155	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NGF—glaucoma	4.46e-05	0.000155	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NGF—glaucoma	4.45e-05	0.000155	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CDKN2B—glaucoma	4.42e-05	0.000154	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NTRK2—glaucoma	4.41e-05	0.000153	CbGpPWpGaD
Naloxone—ALB—Hemostasis—FN1—glaucoma	4.34e-05	0.000151	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NGFR—glaucoma	4.27e-05	0.000148	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EDN1—glaucoma	4.24e-05	0.000147	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—C3—glaucoma	4.24e-05	0.000147	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—C3—glaucoma	4.23e-05	0.000147	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS3—glaucoma	4.22e-05	0.000147	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.22e-05	0.000147	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.19e-05	0.000146	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.18e-05	0.000145	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.15e-05	0.000144	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—MTHFR—glaucoma	4.11e-05	0.000143	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.07e-05	0.000141	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NTRK1—glaucoma	4.06e-05	0.000141	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TXN—glaucoma	4.03e-05	0.00014	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDKN1B—glaucoma	3.96e-05	0.000138	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APOE—glaucoma	3.95e-05	0.000137	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APOE—glaucoma	3.94e-05	0.000137	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CAV1—glaucoma	3.91e-05	0.000136	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NGF—glaucoma	3.9e-05	0.000135	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CAV1—glaucoma	3.9e-05	0.000135	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—glaucoma	3.86e-05	0.000134	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CA1—glaucoma	3.85e-05	0.000134	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—APOE—glaucoma	3.82e-05	0.000133	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CAV1—glaucoma	3.79e-05	0.000132	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NGFR—glaucoma	3.78e-05	0.000131	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDKN2B—glaucoma	3.74e-05	0.00013	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CTSA—glaucoma	3.73e-05	0.00013	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FN1—glaucoma	3.72e-05	0.000129	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FN1—glaucoma	3.71e-05	0.000129	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—C3—glaucoma	3.71e-05	0.000129	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—BAD—glaucoma	3.68e-05	0.000128	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—BAD—glaucoma	3.67e-05	0.000127	CbGpPWpGaD
Naloxone—CREB1—Disease—CDKN1B—glaucoma	3.66e-05	0.000127	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NTRK1—glaucoma	3.6e-05	0.000125	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.59e-05	0.000125	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EDN1—glaucoma	3.59e-05	0.000125	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GSTT1—glaucoma	3.58e-05	0.000125	CbGpPWpGaD
Naloxone—ALB—Metabolism—GSTT1—glaucoma	3.56e-05	0.000124	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CA2—glaucoma	3.52e-05	0.000122	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APOE—glaucoma	3.45e-05	0.00012	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS3—glaucoma	3.45e-05	0.00012	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CAV1—glaucoma	3.42e-05	0.000119	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDKN2B—glaucoma	3.31e-05	0.000115	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NGF—glaucoma	3.3e-05	0.000115	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FN1—glaucoma	3.25e-05	0.000113	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—BAD—glaucoma	3.22e-05	0.000112	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EDN1—glaucoma	3.18e-05	0.00011	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—C3—glaucoma	3.13e-05	0.000109	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GSTT1—glaucoma	3.12e-05	0.000108	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOS3—glaucoma	2.96e-05	0.000103	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOS3—glaucoma	2.95e-05	0.000102	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NGF—glaucoma	2.92e-05	0.000102	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APOE—glaucoma	2.92e-05	0.000101	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.89e-05	0.0001	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CAV1—glaucoma	2.89e-05	0.0001	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.87e-05	9.98e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—NOS3—glaucoma	2.86e-05	9.95e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCA1—glaucoma	2.86e-05	9.92e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP1B1—glaucoma	2.86e-05	9.92e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCA1—glaucoma	2.84e-05	9.87e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP1B1—glaucoma	2.84e-05	9.87e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—C3—glaucoma	2.78e-05	9.65e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FN1—glaucoma	2.75e-05	9.56e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—BAD—glaucoma	2.72e-05	9.44e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—glaucoma	2.62e-05	9.1e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APOE—glaucoma	2.59e-05	8.99e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOS3—glaucoma	2.59e-05	8.98e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CDKN1B—glaucoma	2.56e-05	8.9e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CAV1—glaucoma	2.56e-05	8.9e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CDKN1B—glaucoma	2.55e-05	8.87e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ABCA1—glaucoma	2.49e-05	8.64e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP1B1—glaucoma	2.49e-05	8.64e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—VEGFA—glaucoma	2.49e-05	8.64e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TXN—glaucoma	2.48e-05	8.62e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FN1—glaucoma	2.44e-05	8.47e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—BAD—glaucoma	2.41e-05	8.37e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—glaucoma	2.37e-05	8.25e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—glaucoma	2.37e-05	8.22e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GSTM1—glaucoma	2.28e-05	7.93e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GSTM1—glaucoma	2.27e-05	7.89e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CDKN1B—glaucoma	2.24e-05	7.78e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOS3—glaucoma	2.18e-05	7.59e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VEGFA—glaucoma	2.13e-05	7.4e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VEGFA—glaucoma	2.12e-05	7.38e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—glaucoma	2.07e-05	7.21e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MTHFR—glaucoma	2.02e-05	7.01e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—MTHFR—glaucoma	2.01e-05	6.97e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GSTM1—glaucoma	1.99e-05	6.91e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOS3—glaucoma	1.94e-05	6.73e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GSTT1—glaucoma	1.92e-05	6.68e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDKN1B—glaucoma	1.89e-05	6.58e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—glaucoma	1.88e-05	6.53e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOE—glaucoma	1.88e-05	6.53e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOE—glaucoma	1.87e-05	6.49e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VEGFA—glaucoma	1.86e-05	6.47e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CAV1—glaucoma	1.86e-05	6.47e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CAV1—glaucoma	1.85e-05	6.43e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MTHFR—glaucoma	1.76e-05	6.11e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—glaucoma	1.75e-05	6.09e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDKN1B—glaucoma	1.68e-05	5.83e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOE—glaucoma	1.64e-05	5.69e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CAV1—glaucoma	1.62e-05	5.63e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—glaucoma	1.61e-05	5.59e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—glaucoma	1.6e-05	5.58e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VEGFA—glaucoma	1.57e-05	5.47e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—glaucoma	1.55e-05	5.4e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCA1—glaucoma	1.53e-05	5.33e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP1B1—glaucoma	1.53e-05	5.33e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—glaucoma	1.41e-05	4.89e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NOS3—glaucoma	1.41e-05	4.89e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—NOS3—glaucoma	1.4e-05	4.86e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VEGFA—glaucoma	1.4e-05	4.85e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—glaucoma	1.29e-05	4.47e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—glaucoma	1.28e-05	4.45e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NOS3—glaucoma	1.23e-05	4.26e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GSTM1—glaucoma	1.23e-05	4.26e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—glaucoma	1.19e-05	4.13e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—glaucoma	1.12e-05	3.9e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MTHFR—glaucoma	1.08e-05	3.76e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—glaucoma	1.05e-05	3.66e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOE—glaucoma	1.01e-05	3.5e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CAV1—glaucoma	9.99e-06	3.47e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NOS3—glaucoma	7.55e-06	2.62e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—glaucoma	6.91e-06	2.4e-05	CbGpPWpGaD
